Format

Send to

Choose Destination
Br J Pharmacol. 2016 Jul;173(14):2182-94. doi: 10.1111/bph.13505. Epub 2016 Jun 2.

Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine.

Author information

1
Dipartimento di Scienze del Farmaco, Università del Piemonte Orientale, Novara, Italy.

Abstract

In this review, we focus on the secreted form of nicotinamide phosphoribosyltransferase (NAMPT); extracellular NAMPT (eNAMPT), also known as pre-B cell colony-enhancing factor or visfatin. Although intracellular NAMPT is a key enzyme in controlling NAD metabolism, eNAMPT has been reported to function as a cytokine, with many roles in physiology and pathology. Circulating eNAMPT has been associated with several metabolic and inflammatory disorders, including cancer. Because cytokines produced in the tumour micro-environment play an important role in cancer pathogenesis, in part by reprogramming cellular metabolism, future improvements in cancer immunotherapy will require a better understanding of the crosstalk between cytokine action and tumour biology. In this review, the knowledge of eNAMPT in cancer will be discussed, focusing on its immunometabolic function as a metabokine, its secretion, its mechanism of action and possible roles in the cancer micro-environment.

PMID:
27128025
PMCID:
PMC4919578
DOI:
10.1111/bph.13505
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center